-
Gait Activation Improves Hypomimia in Parkinson’s Disease
-
Gait Kinematics as Biomarkers of Preclinical Parkinson’s Disease: A Systematic Review of Sensor-Based Studies
-
Gait parameters, Imaging features, and CSF tap test in idiopathic Normal Pressure Hydrocephalus (iNPH) Is composite testing the way to go
-
Gauging The Applicability Of The Global Assessment Scale for Wilson’s Disease in Brazil
-
GBA1 deficiency promotes tau and TDP-43 co-pathology
-
GBA1 L444P mutation increases susceptibility to neuroinflammation and promotes pro-inflammatory immune responses
-
Gelsolin and Secretogranin-3 induce Parkinsonian features in rodent models.
-
Gender Differences in Cervical Dystonia Patients
-
Genetic analysis of Mongolian patients with Parkinson’s Disease
-
Genetic analysis of the SLC38A6 gene in Chinese patients with essential tremor
-
Genetic analysis of the X chromosome and Parkinson’s disease
-
Genetic Architecture of Essential Tremor: Clinical Misdiagnosis and Structural Variant Contributions to Neurobiological Pathways
-
Genetic Architecture Of Intracranial Brain Calcification: A Systematic Review
-
Genetic determinants of cognitive performance in Parkinson’s disease: impact of distal regulatory variation at the SNCA locus in the gp2 cohort
-
Genetic Disorders Presenting With Tremor at Onset: MDSGene systematic literature review
-
Genetic Landscape of Hereditary Ataxia in a Highly Consanguineous Population: A Nationwide Multicenter Study
-
Genetic Modifiers of Age at Onset for Parkinson’s Disease in European Populations
-
Genetic modifiers of the clinical phenotype in Spinocerebellar Ataxia type 2. 25 years of candidate genes studies and the forthcoming GWAS era
-
Genetic Predictors in Dystonia: A Phenotypic Analysis.
-
Genetic Rare Variation in Early-Onset Neurodegenerative Movement Disorders: A Clinicopathologic Study.
-
Genetic risk factors reduce the risk of diabetes mellitus in Parkinsons disease
-
Genetic spectrum of spinocerebellar ataxia type 27b (atx-fgf14-gaa): a single-center study
-
Genetic Variation in KCNJ6 Gene Increases Risk of Impulse Disorders in Parkinson’s Disease: A Two-Cohort Study
-
Genetically proven Juvenile-Onset Niemann–Pick Disease Type C Presenting with Dystonia- Ataxia syndrome.
-
Genome-wide Discovery of GBA1 Modifiers in Parkinsons Disease Carriers across Populations from the Global Parkinsons Genetics Program
-
Genome-wide Discovery of Genetic Modifiers of LRRK2 risk in Parkinson’s Disease Carriers across European Populations
-
Genomic analysis of an Argentinean PSP cohort
-
Genomic Insights into Parkinson’s Disease: LARGE-PD and PD GENEration Collaboration in El Salvador
-
Genotype Matters: Vagus Nerve Atrophy in GBA-Associated Parkinson’s Disease
-
Genotype-Phenotype Correlations in KCNMA1 Channelopathy: A Comparative Analysis of Gain-of-Function and Loss-of-Function Variants in a Korean Cohort and Literature Review
-
Genotype-Specific Risk Factors for Falls in Spinocerebellar Ataxia: A Cross-Sectional Analysis of SCA1, SCA2, SCA3, and SCA6
-
Global and Turkish Comorbidity Profiles in Parkinson’s Disease: The ANPAR Cohort and a Systematic Review
-
Global Functional Trajectory and Predictors of Improvement in Idiopathic Normal Pressure Hydrocephalus Following Shunt Surgery
-
Global Momentum in Parkinson’s Disease Therapeutics: Ten-Year Trends in Mechanisms, Modalities, and Clinical Endpoints
-
Global Parkinson´s Symptoms Index Correlates with Changes in Quality of Life and Autonomy for Activities of Daily Living
-
Global Performance Patterns in the MDS-UPDRS Motor Certification Program: A five-year Analysis
-
Global Roles of Nurses and Advanced Practice Providers in Parkinson’s Disease Care: Findings from an International Workforce Survey
-
Global Trends in Parkinson’s Disease Research: A Bibliometric Snapshot (2021–2024)
-
Globus Pallidus Internus Deep Brain Stimulation for Dystonia in COX20-Related Mitochondrial Complex IV Deficiency (MC4DN11): First Reported Case
-
GLP-1 Receptor Agonists in Movement Disorders: From Parkinson’s Disease to the Broader Spectrum — Mechanisms, Evidence, and Future Directions
-
GLP1R Expression and Parkinson’s Disease and Related Disorders in GLP-1RA–Treated Type 2 Diabetes
-
Glymphatic dysfunction in patients with Parkinson’s disease is associated with regional amygdala and putamen degeneration
-
Grey Matter Volume and White Matter Microstructural Alterations in PRKN-PD
-
Grip strength and hand distress in de novo Parkinson´s disease: support for early rehabilitation
-
GSTM1 and GSTT1 null genotypes as candidate modifiers of clinical severity and genomic instability in Cuban patients with Spinocerebellar Ataxia type 2
-
Gut Barrier Failure In Parkinson Disease: Reduced Colonic Resilience In Moderate Disease And Spontaneous Pan-Intestinal Leak In Severe Disease
-
Gut Microbiome Metagenomics in Parkinson’s Disease Stratified by the Asian-Prevalent LRRK2 Variants p.G2385R and p.R1628P
2026 International Congress
October 4-8, 2026. Seoul, Korea.
